Evidence map›Paper›PMID 27381906›Full record

ArticleBlood2016

Long noncoding RNAs in B-cell development and activation.

Tiago F Brazão, Jethro S Johnson, Jennifer Müller, Andreas Heger, Chris P Ponting, Victor L J Tybulewicz

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 126 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Challenges and Perspectives in ncRNA Research.Experientia supplementum (2012) · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Non-coding RNA research · 2024
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tiago F BrazãoThe Francis Crick Institute, London, United Kingdom;ORCID 0000-0002-0760-4873
Jethro S JohnsonMedical Research Council (MRC) Computational Genomics Analysis and Training Centre, MRC Functional Genomics Unit, Department of Physiology Anatomy and Genetics, University of Oxford, Oxford, United Kingdom; and.ORCID 0000-0001-9155-054X
Jennifer MüllerThe Francis Crick Institute, London, United Kingdom;
Andreas HegerMedical Research Council (MRC) Computational Genomics Analysis and Training Centre, MRC Functional Genomics Unit, Department of Physiology Anatomy and Genetics, University of Oxford, Oxford, United Kingdom; and.ORCID 0000-0001-7720-0447
Chris P PontingMedical Research Council (MRC) Computational Genomics Analysis and Training Centre, MRC Functional Genomics Unit, Department of Physiology Anatomy and Genetics, University of Oxford, Oxford, United Kingdom; and.ORCID 0000-0003-0202-7816
Victor L J TybulewiczThe Francis Crick Institute, London, United Kingdom; Imperial College, London, United Kingdom.ORCID 0000-0003-2439-0798
Genomics (United Kingdom) · GBThe Francis Crick Institute · GB

Funding

Cancer Research UKMedical Research Council MC_UU_12021/1Medical Research Council U117527252Wellcome Trust
6 · The paper itself

Abstract

Long noncoding RNAs (lncRNAs) are potentially important regulators of cell differentiation and development, but little is known about their roles in B lymphocytes. Using RNA-seq and de novo transcript assembly, we identified 4516 lncRNAs expressed in 11 stages of B-cell development and activation. Most of these lncRNAs have not been previously detected, even in the closely related T-cell lineage. Comparison with lncRNAs previously described in human B cells identified 185 mouse lncRNAs that have human orthologs. Using chromatin immunoprecipitation-seq, we classified 20% of the lncRNAs as either enhancer-associated (eRNA) or promoter-associated RNAs. We identified 126 eRNAs whose expression closely correlated with the nearest coding gene, thereby indicating the likely location of numerous enhancers active in the B-cell lineage. Furthermore, using this catalog of newly discovered lncRNAs, we show that PAX5, a transcription factor required to specify the B-cell lineage, bound to and regulated the expression of 109 lncRNAs in pro-B and mature B cells and 184 lncRNAs in acute lymphoblastic leukemia.

Indexed as

AnimalsB-LymphocytesCell Transformation, NeoplasticChromatinEnhancer Elements, GeneticFemaleGene Expression RegulationGenetic LociHumansLymphocyte ActivationMice, Inbred C57BLOpen Reading FramesPAX5 Transcription FactorPrecursor B-Cell Lymphoblastic Leukemia-LymphomaPromoter Regions, GeneticRNA, Long NoncodingChromatinPAX5 Transcription FactorRNA, Long Noncoding

Identifiers

PMID27381906
PMCPMC5000579
OpenAlexW2463910465

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.